Idis Company Profile

19:43 EST 17th November 2017 | BioPortfolio

IDIS, is the leading authority in the field of named-patient medicine sourcing and supply. Having built an impressive reputation as a reliable and ethical source of named-patient medicines; IDIS prides itself on helping to provide a lifeline to patients and the medical profession.
IDIS supports pharmacists and physicians globally by sourcing and supplying medicines on an ethical named-patient basis. Working with IDIS provides you with instant access to a multitude of global avenues to fulfil your named-patient medicine requirements. IDIS works in partnership with the pharmaceutical and biotechnology industry to establish and deliver pre-launch named-patient management programmes, develop solutions for a discontinued brand, manage temporary supply problems and source and supply medicines for clinical trials. IDIS has specialist in-house expertise in legal and regulatory requirements, technical and clinical support, pharmacovigilance, import/export requirements and distribution and storage to deal with the complexities associated with handling named-patient medicines in an ethical and professional manner.


IDIS HouseChurchfield Road
KT13 8DB
United Kingdom


Phone: 44 (0)1932 824 100
Fax: 44 (0)1932 824 200

News Articles [2 Associated News Articles listed on BioPortfolio]

CORRECTING AND REPLACING: Clinigen Signs Exclusive Supply Agreements in Global Access With Mitsubishi Tanabe, Shionogi and Romark

The fifth paragraph of release dated June 21, 2017 07:00 AM BST should read: "Under this new agreement, Idis GA will supply and distribute argatroban on an exclusive, unlicensed, ...

Clinigen and Sarepta Therapeutics launch a Managed Access Program to treat patients with Duchenne Muscular Dystrophy amenable to exon 51 skipping

Clinigen Group plc’s (AIM: CLIN, 'Clinigen') Idis Managed Access division and Sarepta Therapeutics Inc. (NASDAQ: SRPT) have initiated a Managed Access Program (MAP) for eteplirs...

Drugs and Medications [0 Results]


PubMed Articles [2 Associated PubMed Articles listed on BioPortfolio]

Dreams deferred: Contextualizing the health and psychosocial needs of undocumented Asian and Pacific Islander young adults in Northern California.

There are currently 1.5 million undocumented Asians and Pacific Islanders (APIs) in the US. Undocumented API young adults, in particular, come of age in a challenging political and social climate, but...

Improving drug delivery strategies for lymphatic filariasis elimination in urban areas in Ghana.

The Global Program to Eliminate Lymphatic Filariasis (GPELF) advocates for the treatment of entire endemic communities, in order to achieve its elimination targets. LF is predominantly a rural disease...

Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

IDIS Project Work Package 2: Establishing a Biobank at ITM and Collaborating Centres

The IDIS study aims to develop a new rapid diagnostic test for invasive salmonellosis using samples (blood, urine) collected from patients with fever and healthy controls at the Institute ...

Companies [2 Associated Companies listed on BioPortfolio]


IDIS, is the leading authority in the field of named-patient medicine sourcing and supply. Having built an impressive reputation as a reliable and ethical source of named-patient medicines; IDIS pride...

TWF Development Associates

TradeWithFrance was born out of the cooperation of three founding entities: GBC, IDIS and Ubizquity Consulting.While firm believers in the necessity of establishing Flesh-to-Flesh relationships for an...

More Information about "Idis" on BioPortfolio

We have published hundreds of Idis news stories on BioPortfolio along with dozens of Idis Clinical Trials and PubMed Articles about Idis for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Idis Companies in our database. You can also find out about relevant Idis Drugs and Medications on this site too.

Quick Search

Relevant Topics

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Corporate Database Quicklinks

Searches Linking to this Company Record